High-potency PD-1/PD-L1 degradation induced by Peptide-PROTAC in human cancer cells.

Dai, Meng-Yuan; Shi, Yu-Ying; Wang, An-Jin; Liu, Xue-Lian; Liu, Miao; Cai, Hong-Bing

Dai, Meng-Yuan; Shi, Yu-Ying; Wang, An-Jin; Liu, Xue-Lian; Liu, Miao; Cai, Hong-Bing.

Afiliación

Dai MY; Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Shi YY; Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan, China.
Wang AJ; Hubei Cancer Clinical Study Center, Wuhan, China.
Liu XL; Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Liu M; Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan, China.
Cai HB; Hubei Cancer Clinical Study Center, Wuhan, China.

Cell Death Dis ; 13(11): 924, 2022 11 04.

Article en En | MEDLINE | ID: mdl-36333311

Asunto(s)

Antígeno B7-H1; Neoplasias; Humanos; Antígeno B7-H1/metabolismo; Línea Celular Tumoral; Neoplasias/metabolismo; Péptidos/farmacología; Receptor de Muerte Celular Programada 1/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Neoplasias Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google